Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 508)
Posted On: 07/02/2022 4:51:11 PM
Post# of 154120
Posted By: ohm20
Re: thriftycents #125865
The study involving treatment of leronlimab along with stem cell transplant will work effectively if 100% receptor occupancy is maintained. The downside is it would only be used with those already getting a stem cell transplant.

His most recent proposal that he got a grant for is using AAV vectors for delivery of leronlimab. This may be where he hopes to have a single injection of leronlimab last for months. Since viral reservoirs will still exist this is not a cure. As far as I'm aware AAV is used for drug delivery so I don't know where the "body itself producing leronlimab" from the CC comes from.

https://reporter.nih.gov/project-details/10371617#details

A long time ago I had proposed using leronlimab with another drug that would flush out HIV viral reservoirs to effectuate a cure. Interestingly Dr. Sacha will be involved in two research projects involved in clearing viral reservoirs.

https://grantome.com/grant/NIH/R33-AI128970-04

https://app.dimensions.ai/details/grant/grant.3805851













(8)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site